The universally accepted strategy in the management of diabetes is the administration of insulin jabs and antidiabetic prescriptions containing oral hypoglycemic drugs such as insulin secretagogues, incretin agonists, insulin sensitizers, dipeptidyl peptidase-4 inhibitors, α-glucosidase inhibitors to enhance a controlled blood glucose level [6, 7]. The gene discussed is INS; the disease is diabetes mellitus.